Alteration of endometrial receptivity in rats with ovarian hyperstimulation syndrome

References

• Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V. 1996. Plasma inflammatory cytokine correlate to the ovarian hyperstimulation syndrome. Human Reproduction 11:1381–1386.
   PubMed Web of Science ®Google Scholar
• Aghajanova L, Stavreus-Evers A, Nikas Y, Hovatta O, Landgren BM. 2003. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertility and Sterility 79(Suppl 1): 808–814.
   PubMedGoogle Scholar
• Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C et al. 2007. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Human Reproduction 22:3210–3214.
   PubMed Web of Science ®Google Scholar
• Binder H, Dittrich R, Einhaus F, Krieg J, Müller A, Strauss R et al. 2007. Update on ovarian hyperstimulation syndrome: Part 1 Incidence and pathogenesis. International Journal of Fertility and Women's Medicine 52:11–26.
   PubMedGoogle Scholar
• Budev MM, Arroliga AC, Falcone T. 2005. Ovarian hyperstimulation syndrome. Critical Care Medicine 33:110:301–306.
   Google Scholar
• Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A, Gamerre M. 2011. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertility and Sterility 95:1629–1632.
   PubMedGoogle Scholar
• Develioglu OH, Hsiu JG, Nikas G, Toner JP, Oehringer S, Jones HW Jr. 1999. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertility and Sterility 71: 1040–1047.
   PubMed Web of Science ®Google Scholar
• Geva E, Lessing JB, Lerner-Geva L, Azem F, Yovel I, Amit A. 1997. Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome. Fertility and Sterility 68:133–137.
   PubMedGoogle Scholar
• Griesinger G, Berndt H, Schultz L, Schultze-Mosgau A, Diedrich K, von Otte S. 2011. Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study. Reproductive Biomedicine Online 22:133–139.
   PubMedGoogle Scholar
• Hsieh YY, Chang CC, Tsai HD. 2008. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization. Taiwanese Journal of Obstetrics and Gynecology 47:66–74.
   PubMed Web of Science ®Google Scholar
• Karagouni EE, Chryssikopoulos A, Mantzavinos T, Kanakas N, Dotsika EN. 1998. Interleukin-1beta and interleukin-1alpha may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer. Fertility and Sterility 70:553–559.
   PubMedGoogle Scholar
• Laird SM, Tuckerman EM, Li TC. 2006. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reproductive Biomedicine Online 13:13–23.
   PubMed Web of Science ®Google Scholar
• Lessey BA, Castelbaum AJ, Wolf L, Greene W, Paulson M, Meyer WR et al. 2000. Use of integrins to date the endometrium. Fertility and Sterility 73:779–787.
   PubMedGoogle Scholar
• Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty Jr KS. 1988. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 67:334–340.
   PubMed Web of Science ®Google Scholar
• Levy C, Robel P, Gautray JP, De Brux J, Verma U, Descomps B et al. 1980. Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. American Journal of Obstetrics and Gynecology 136:646–651.
   PubMed Web of Science ®Google Scholar
• Ludwig M, Jelkmann W, Bauer O, Diedrich K. 1999. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Human Reproduction 14:2437–2441.
   PubMedGoogle Scholar
• Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington CC 3rd, Stern JE. 2010. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertility and Sterility 94:1399–1404.
   PubMed Web of Science ®Google Scholar
• Manolopoulos K, Lang U, Gips H, Braems GA. 2001. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 99:226–231.
   PubMed Web of Science ®Google Scholar
• McGinnis W, Krumlauf R. 1992. Homeobox genes and axial patterning. Cell 68:283–302.
   PubMed Web of Science ®Google Scholar
• Mikołajczyk M, Skrzypczak J, Wirstlein P. 2011. No correlation between pinopode formation and LIF and MMP2 expression in endometrium during implantation window. Folia Histochemica et Cytobiologica 49:615–621.
   PubMedGoogle Scholar
• Mikolajczyk M, Wirstlein P, Skrzypczak J. 2007. The impact of leukemia inhibitory factor in uterine flushing on the reproductive potential of infertile women-a prospective study. American Journal of Reproductive Immunology 58:65–74.
   PubMedGoogle Scholar
• Nardo LG, Cheema P, Gelbaya TA, Horne G, Fitzgerald CT, Pease EH et al. 2006. The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization. Human Fertility (Cambridge, England) 9:175–180.
   PubMedGoogle Scholar
• Nastri CO, Ferriani RA, Rocha IA, Martins WP. 2010. Ovarian hyperstimulation syndrome: pathophysiology and prevention. Journal of Assisted Reproduction and Genetics 27:121–128.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Genazzani AR, Petraglia F, Schwartz A, Shelef M, Ben-Rafael Z. 1997. Interleukin-2 production by cultured human granulosa cells. International Journal of Fertility and Women's Medicine 42:297–300.
   PubMedGoogle Scholar
• Palomba S, Falbo A, Carrillo L, Villani MT, Orio F, Russo T et al. 2011. The METformin in High Responder Italian Group. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.Fertility and Sterility 96:1384–1390.
   PubMed Web of Science ®Google Scholar
• Pantos K, Nikas G, Makrakis E, Stavrou D, Karantzis P, Grammatis M. 2004. Clinical value of endometrial pinopodes detection in artificial donation cycles. Reproductive Biomedicine Online 9:86–90.
   PubMed Web of Science ®Google Scholar
• Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM et al. 2006. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertility and Sterility 85:112–120.
   PubMed Web of Science ®Google Scholar
• Quinn CE, Casper RF. 2009. Pinopodes: a questionable role in endometrial receptivity. Human Reproduction Update 15:229–236.
   PubMed Web of Science ®Google Scholar
• Raziel A, Schachter M, Friedler S, Ron-El R. 2009. Outcome of IVF pregnancies following severe OHSS. Reproductive Biomedicine Online 19:61–65.
   PubMedGoogle Scholar
• Revel A, Barak V, Lavy Y, Anteby E, Abramov Y, Schenker JJ et al. 1996. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertility and Sterility 66: 66–71.
   PubMedGoogle Scholar
• Rizk B, Aboulghar M, Smitz J, Ron-El R. 1997. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Human Reproduction Update 3:255–266.
   PubMed Web of Science ®Google Scholar
• Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A. 2008. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Human Reproduction Update 14:321–333.
   PubMed Web of Science ®Google Scholar
• Taylor HS, Arici A, Olive D, Igarashi P. 1998. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. Journal of Clinical Investigation 101:1379–1384.
   PubMed Web of Science ®Google Scholar
• Taylor HS, Heuvel GB, Igarashi P. 1997. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Reproductive Biology 57:1338–1345.
   Google Scholar
• Tsoumpou I, Muglu J, Gelbaya TA, Nardo LG. 2009. Symposium: Update on prediction and management of OHSS. Optimal dose of HCG for final oocyte maturation in IVF cycles: absence of evidence?Reproductive Biomedicine Online 19:52–58.
   PubMedGoogle Scholar
• Ujioka T, Matsuura K, Kawano T, Okamura H. 1997. Role of progesterone in capillary permeability in hyperstimulated rats. Human reproduction (Oxford, England) 12:1629–1634.
   PubMed Web of Science ®Google Scholar
• van de Lagemaat R, Raafs BC, van Koppen C, Timmers CM, Mulders SM, Hanssen RG. 2011. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH. Endocrinology 152:4350–4357.
   PubMedGoogle Scholar
• Vlahos NF, Gregoriou O. 2006. Prevention and management of ovarian hyperstimulation syndrome. Annals of the New York Academy of Science 1092:247–264.
   PubMed Web of Science ®Google Scholar
• Wang J, Armant DR. 2002. Integrin-mediated adhesion and signaling during blastocyst implantation. Cells Tissues Organs 172:190–201.
   PubMed Web of Science ®Google Scholar